tiprankstipranks
Fate Therapeutics (FATE)
NASDAQ:FATE

Fate Therapeutics (FATE) Ownership - Who Owns Fate Therapeutics?

1,095 Followers

Fate Therapeutics (FATE) Ownership Overview

28.67%25.01%17.23%29.09%
28.67% Insiders
17.23% Other Institutional Investors
29.09% Public Companies and
Individual Investors
The ownership structure of Fate Therapeutics (FATE) stock is a mix of institutional, retail and individual investors. Approximately 42.24% of the company’s stock is owned by Institutional Investors, 28.67% is owned by Insiders and 29.09% is owned by Public Companies and Individual Investors.
The ownership structure of Fate Therapeutics (FATE) stock is a mix of institutional, retail and individual investors. Approximately 42.24% of the company’s stock is owned by Institutional Investors, 28.67% is owned by Insiders and 29.09% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 10, 2024Sold$30712
Jan 10, 2024
Cindy Tahl
Gc & Secretary
Sold$47519
Jan 10, 2024
Scott Wolchko
President & Ceo,director
Sold$62889
Jan 10, 2024
Bahram Valamehr
Chief R&d Officer
Sold$49367

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$401369
Dec 31, 2023Sold$534820
Dec 31, 2023Bought$1441261

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
5,913,683Institution5.96%31,165,109
5,425,462Institution5.47%28,592,185
4,941,265Institution4.98%26,040,467
3,220,467Institution3.25%16,971,861
2,925,330Institution2.95%15,416,489
2,515,964Institution2.54%13,259,130
1,671,717Institution1.68%8,809,949
1,520,007Institution1.53%8,010,437
1,438,594Institution1.45%7,581,390
1,099,314Institution1.11%5,793,385

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,425,462Institution5.47%28,592,185
2,925,330Institution2.95%15,416,489
2,515,964Institution2.54%13,259,130
1,520,007Institution1.53%8,010,437
1,438,594Institution1.45%7,581,390
1,099,314Institution1.11%5,793,385
967,674Institution0.98%5,099,642
931,034Institution0.94%4,906,549
768,095Institution0.77%4,047,861
635,972Institution0.64%3,351,572

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,795,382Institution5.84%31,179,155
3,040,842Institution3.06%22,319,780
2,037,021Institution2.05%10,735,101
1,249,412Institution1.26%9,170,684
796,297Institution0.80%4,196,485
495,145Institution0.50%2,609,414
315,429Institution0.32%2,315,249
389,978Institution0.39%2,098,082
271,623Institution0.27%1,993,713
374,859Institution0.38%1,975,507

FAQ

Who Owns Fate Therapeutics (FATE)?
According to the latest TipRanks data, approximately 17.23% of the company's stock is held by institutional investors, 28.67% is held by insiders, and 29.09% is held by retail investors.
    What percentage of Fate Therapeutics (FATE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 17.23% of Fate Therapeutics (FATE) stock is held by institutional investors.
      What percentage of Fate Therapeutics (FATE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 29.09% of Fate Therapeutics (FATE) stock is held by retail investors.
        Who owns the most shares of Fate Therapeutics (FATE)?
        SPDR owns the most shares of Fate Therapeutics (FATE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis